Pressroom | Career | Contact | Imprint | Sitemap

Home

About Nano2Life

Research

Activities

About NanoBio

e-Learning

Databases

Newsletter
Subscribe to our Newsletter and get Information about Nano2Life:

Search

Login
[Login to members area]
[Password forgotten?]


One of 23 N2L Partners:


News

Nanomed Round Table - CSA Project in FP7

The Nanomed Round Table is a CSA Project in FP7 which had its kick-off meeting on the 19./20. January 2009. The main purpose is to provide to European stakeholders a set of recommendations to support decision making regarding nanomedical innovations. These recommendations will be based on a thorough analysis of existing documents, multi-stakeholder debate, and construction of scenarios on the possible consequences and impacts of nanomedicine. A further aim will be to raise awareness and understanding of the field and associated issues among policy makers and the wider public and to propose longer term structures to consider nanomedical issues in the future.

 

The Round Table will bring together stakeholders in five Working Groups under the Chairmanship of Professor Sir John Beringer, formerly Pro Vice-Chancellor, University of Bristol. The Working Groups and their Convenors will be:

  • Regulation: Mark Cantley (formerly Adviser, Life Sciences and Biotechnology, Directorate-General for Research, European Commission)
  • Economic Impact : Dr Françoise Charbit Technological Research Division, Commissariat à l'Énergie Atomique (CEA), Grenoble, France
  • Communication: Professor Dr Wolfgang Heckl, Ludwig-Maximilians-Universität & Director, Deutsches Museum, München, Germany
  • Patient Needs: Alastair Kent, Director, Genetic Interest Group, UK and Chairman, European Platform for Patients' Organisations, Science and Industry (EPPOSI)
  • Ethics & Societal Impact: Professor Alfred Nordmann, Technische Universität Darmstadt, Germany & University of South Carolina, USA

The coordinator will be Professor Julian Kinderlerer, Delft University of Technology, The Netherlands & University of Cape Town, South Africa and member of the European Group on Ethics. Management will be by Dr Klaus-Michael Weltring, Managing Director, bioanalytik muenster, Germany and Dr David Bennett, St Edmund's College, University of Cambridge and Delft University of Technology, The Netherlands & Director, Cambridge Biomedical Consultants Ltd. Richard Hayhurst, Hayhurst Media, will advise on and carry out public relations.



Contact
Klaus-Michael Weltring
+49 (0)251 9801212
weltring[at]bioanalytik-muenster.de




NanoBio-News
Multifunctional pharmaceutical nanocarriers
Carriers are needed for a number of reasons in drug delivery, e.g. to protect the drug from the body, to protect the body from the drug and to adjust the pharmacokinetics, i.e. distribution and clearance, of the drug. [more]
Nanotechnologies in the Food Sector
The UK’s House of Lords Science and Technology Committee today published the findings of their 2009 inquiry into the use of nanotechnologies in the food sector. [more]
[NanoBio-News-Archive]



Useful Links
Useful web resources concerning nanobiotechnology
[Links]